Novo Nordisk realises a major expansion in Clayton, NC (USA). The project will enhance Novo Nordisk’s manufacturing capabilities with more than 1.4 million square feet of new space.
https://european-biotechnology.com/wp-content/uploads/2024/07/New-Expansion-Site-Rendering-in-Clayton-1.jpg10552500Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2024-06-28 14:44:522024-07-16 18:41:45Novo Nordisk expands footprint in USA